Kaushal Agarwal
Founding Partner at Oxford Varsity Fund
Oxford, England
Kaushal Agarwal, Founding Partner at Oxford Varsity Fund is an active investor based in Oxford, England. This profile covers what Kaushal Agarwal backs, at which stage, and how founders can reach out in 2026.
Learning
- Investor type
- VC
- Stages
- Early Stage Venture
- Invests in
- Fintech
- Location
- Oxford, England
- Typical check
- $500K
How to reach Kaushal Agarwal
Angels and operators like Kaushal Agarwal reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Kaushal Agarwal
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Kaushal Agarwal invest in?
Kaushal Agarwal invests in Fintech, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Kaushal Agarwal invest at?
Kaushal Agarwal typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.
What is Kaushal Agarwal's typical check size?
Kaushal Agarwal typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.
How do I contact Kaushal Agarwal?
Unlock Kaushal Agarwal's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.